Navigation Links
Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
Date:8/26/2009

CHADDS FORD, Pa., Aug. 26 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the commencement of a cash tender offer by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes due 2024 (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions Inc.'s wholly-owned subsidiary. The purpose of the tender offer is to acquire any and all Notes to reduce the consolidated interest expense of Endo.

The tender offer is being made pursuant to an Offer to Purchase, dated August 26, 2009, and related Letter of Transmittal, dated August 26, 2009, which set forth the terms and conditions and a more detailed description of the tender offer. The tender offer will expire at 5:00 p.m., New York City time, on September 24, 2009 (the "expiration time"), unless extended or earlier terminated.

The following table summarizes the material pricing terms for the tender offer:

                             PRINCIPAL  TENDER OFFER    EARLY     TOTAL EARLY
                 TITLE        AMOUNT    CONSIDERATION   TENDER   CONSIDERATION
    CUSIP NO.   OF NOTES    OUTSTANDING     (1)        PAYMENT(1)    (1)(2)

    52328N AA3  Ledgemont
                PhaRMA(SM)
                Secured 16%
                Notes due
                2024        $105,000,000    $950          $50        $1,000

    (1) Per $1,000 principal amount of Notes accepted for payment by Endo
        Pharmaceuticals Solutions Inc.
    (2) The total early consideration includes the early tender payment and
        is payable only in respect of Notes validly tendered (and not
        validly withdrawn) at or prior to 5:00 p.m., New York City time, on
        September 9, 2009, unless extended (the "early t
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Robin Leedy & Associates Wins Social Media Program For Union Springs Pharmaceuticals
2. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
3. Raptor Pharmaceuticals Raises $5 Million
4. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
5. The Rossbacher Law Firm, Hagens Berman Sobol Shapiro LLP, Wilentz Goldman & Spitzer, P.A., Reed Smith LLP and Thompson Hine LLP, Announce the Proposed Settlement of a Class Action Lawsuit Concerning Estratest and Solvay Pharmaceuticals, Inc.
6. NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
7. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
8. Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
9. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
10. Adamas Pharmaceuticals Raises $40 Million in Series D Financing
11. Transcept Pharmaceuticals Reports Second Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... As testosterone therapy lawsuit filings ... and blood clots from using testosterone products such as ... shows that the male hormone testosterone may increase the ... published in the Proceedings of the National Academy of ... group of male rats with naturally occurring colon cancer. ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
(Date:12/20/2014)... DePuy Pinnacle hip lawsuits ( ... the artificial hip system was defectively designed continue ... Bernstein Liebhard LLP reports. According to an Order ... on December 2nd, counsel in 10 DePuy Pinnacle ... on November 19, 2014, with depositions to conclude ...
(Date:12/20/2014)... Angeldress.co.uk, the distinguished wedding dress manufacturer and ... fans. The company has recently updated its official blog ... holiday season, Angeldress Blog has recommended some ... Angeldress.co.uk prides itself in offering a huge selection of ... the company’s outfits are very carefully selected based on ...
(Date:12/20/2014)... Viejo, California (PRWEB) December 20, 2014 ... announced the release of a new plugin for Final ... Film Studios. , “TranSlice Volume 5 allows users to ... hand draw it.” Said Christina Austin, CEO of Pixel ... add level of professionalism while maintaining an easy to ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... safeguards and NHS red tape following the Alder Hey ... according to researchers//. With restrictions on approaching study volunteers, ... many doctors have been deterred from getting studies up ... at Leeds University said, "That's a disaster and it ...
... tiny particles in the air is inhaled, University of ... , nano-sized particles quickly traverse the pathway and make ... is published in the August issue of Environmental Health ... which the researchers found, that could signal inflammation and ...
... supermarkets in UK, namely Tesco, Sainsbury’s, and Asda have decided ... supermarkets have announced deadlines for removing hydrogenated oil, which is ... It has been explained that trans fatty acid or trans ... risk of obesity and heart disease, and has also been ...
... routine pregnancy examinations to check a baby is in a ... researchers have explained that simple palpation, which is the feeling ... cases of abnormal lie, where in a baby is not ... is very important for a doctor to know the lie ...
... knowledge that breast-feeding gives babies the best start in ... are breast-fed beyond none months are prone to allergy.// ... months is known to offer protection against allergies like ... months may increase the risk of developing allergies rather ...
... and Drug Administration has approved a drug called Famvir as ... //The drug is manufactured by Novartis Pharmaceuticals Corp and is ... ,The drug can be consumed as 1,000 milligrams doses twice ... herpes and this drug does not do so, but relieves ...
Cached Medicine News:Health News:Medical researchers being stifled by NHS Red tape 2Health News:Nano-sized inhaled particles traverse quickly from nose to brain 2Health News:Supermarket Chains In UK To Ban The Use Of Trans Fats 2Health News:Researchers Warn That Routine Physical Examination Could Miss Breech Presentation 2
(Date:12/17/2014)... SCOTTSDALE, Ariz. , Dec. 17, 2014 /PRNewswire/ ... of state-of-the-art interactive music products, today announced that ... Ltd, a leading manufacturer and supplier of innovative ... As part of the agreement, RSL ... Facility bundled solution specifically configured for use within ...
(Date:12/17/2014)... BUENA, N.J. , Dec. 17, 2014  IGI ... announced today the closing of its offering of $125 ... due 2019 (the "Notes").  The Notes were offered and ... 144A under the Securities Act of 1933, as amended ... at a fixed rate of 3.75% per year, payable ...
(Date:12/17/2014)... 17, 2014 PCCA received the Autism ... http://bit.ly/1382OkS ) program seal for best practices in ... highlights medical practices, materials and goods that meet ... Children affected by autism often have unique ... by ingredients found in food and medicine – ...
Breaking Medicine Technology:Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2 Webmedx , the third largest ... a premier supplier of speech recognition and quality ... patient safety by announcing important changes to their ... speech-generated reports. The new changes bring Webmedx into ...
... 2 NewCardio (OTC Bulletin Board: NWCI ) ... Jr., NewCardio,s President and CEO, purchased 128,000 shares during his ... following the Company,s filing of its SEC Form 10-Q and ... "As discussed on our August 12, 2010 ...
Cached Medicine Technology:Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation 2Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation 3NewCardio CEO Increases Equity Position 2NewCardio CEO Increases Equity Position 3NewCardio CEO Increases Equity Position 4
A simple testing set for prescribing aspheric spectacle magnifiers. Redi-glaze lenses are available for instant dispensing which are cut and edged to fit our standard LVA frame....
... to 20 tilting tower ... the vertical, horizontal and ... option to offset the ... ,Filters include Cobalt blue; ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
... Halberg Trial Clips have become ... refractive stand., ,These useful and ... over your patient's spectacle frame. ... three lenses and the rubber ...
Medicine Products: